ClinicalTrials.Veeva

Menu

The Effect of Systemic Dietary Instruction on Management of Plasma Phosphorus Levels in Peritoneal Dialysis (PD) Patients

S

Shanghai Jiao Tong University School of Medicine

Status

Unknown

Conditions

Hyperphosphatemia

Treatments

Other: systemic dietary instruction

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT01329497
phosphorus

Details and patient eligibility

About

Hyperphosphatemia is highly prevalent in PD patients, and it is an independent risk factor for all-cause and cardiovascular mortality in these patients. Effective treatments are limited in suppressing plasma phosphorous. Because of the nearly linear relationship between protein and phosphorus intake, high dietary protein intake (DPI, 1.2-1.3g/kg/d recommended by KDOQI) would load high phosphorus burden in PD patients. It is suggested that hyperphosphatemia is hard to avoid under such a DPI level, even as the patients take sufficient phosphorus blinders and receive high PD dosage. The present study is to investigate whether systemic dietary instruction would show effects on control of hyperphosphatemia in PD patients.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Stable on PD for at least three month
  2. Aged from 18 to 75 years old
  3. Informed consent approval

Exclusion criteria

  1. Malnutrition (based on SGA results)
  2. Infection or inflammation within 1 month
  3. Concurrent wasting disease (i.e. cancer, tuberculosis)

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

interventional group
Experimental group
Treatment:
Other: systemic dietary instruction

Trial contacts and locations

1

Loading...

Central trial contact

Na Jiang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems